New Key Statistics Module, Z-Score and F-Score
OTCPK:BIOCQ Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | 4.96 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -50.90 |
Beneish M-Score | -10.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 74.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.16 |
EV-to-EBITDA | -0.17 |
PEG | -- |
Shares Outstanding M | 2.63 |
Net Margin (%) | -2,257.23 |
Operating Margin % | -2,445.28 |
Pre-tax Margin (%) | -2,266.45 |
Quick Ratio | 1.70 |
Current Ratio | 1.81 |
ROA % (ttm) | -82.63 |
ROE % (ttm) | -213.89 |
ROIC % (ttm) | -156.96 |
Dividend Yield % | -- |
Altman Z-Score | -- |
BIOCQ Number of Guru Trades
BIOCQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:BIOCQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BIOCQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biocept Inc Insider Transactions
No Available Data
News about OTCPK:BIOCQ
Total 0- 1